Literature DB >> 24975527

The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.

Christopher G Chapman1, David T Rubin2.   

Abstract

It has been proposed that effective disease control through abrogation of inflammation in IBD may also reduce CRC risk in these individual patients. This article summarizes the potential for medical therapy to reduce the risk of CRC via primary and secondary prevention, and offers practical ways in which a goal of mucosal improvement or healing may be incorporated into clinical practice.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Inflammatory bowel disease; Medical therapy; Surveillance endoscopy

Mesh：

Substances：

Year:  2014        PMID： 24975527      PMCID： PMC4165430          DOI： 10.1016/j.giec.2014.03.008

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN： 1052-5157


  46 in total

1.  ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease.

Authors:  Jonathan A Leighton; Bo Shen; Todd H Baron; Douglas G Adler; Raquel Davila; James V Egan; Douglas O Faigel; Seng-Ian Gan; William K Hirota; David Lichtenstein; Waqar A Qureshi; Elizabeth Rajan; Marc J Zuckerman; Trina VanGuilder; Robert D Fanelli
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

2.  Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

Authors:  Tine Jess; Edward V Loftus; Fernando S Velayos; Karen V Winther; William J Tremaine; Alan R Zinsmeister; W Scott Harmsen; Ebbe Langholz; Vibeke Binder; Pia Munkholm; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2007-01-11       Impact factor: 10.864

3.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

Review 4.  AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Authors:  Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2010-02       Impact factor: 22.682

5.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

Authors:  R Modigliani; J Y Mary; J F Simon; A Cortot; J C Soule; J P Gendre; E Rene
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

6.  5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.

Authors:  Geoffrey C Nguyen; Aliya Gulamhusein; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2012-07-03       Impact factor: 10.864

7.  Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

Authors:  David T Rubin; Dezheng Huo; Jami A Kinnucan; Mina S Sedrak; Nicole E McCullom; Alana P Bunnag; Elin P Raun-Royer; Russell D Cohen; Stephen B Hanauer; John Hart; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-17       Impact factor: 11.382

8.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 10.  Cutting edge: chemoprevention of colorectal neoplasia in inflammatory bowel disease.

Authors:  Giovanni C Actis; Sonia Tarallo; Floriano Rosina
Journal:  Inflamm Allergy Drug Targets       Date:  2013-02
View more
  8 in total

Review 1.  Mucosal healing in inflammatory bowel disease: Expanding horizon.

Authors:  Jimil Shah; Manik Lal Thakur; Usha Dutta
Journal:  Indian J Gastroenterol       Date:  2019-04-29

Review 2.  Natural compounds as safe therapeutic options for ulcerative colitis.

Authors:  Mukta Gupta; Vijay Mishra; Monica Gulati; Bhupinder Kapoor; Amrinder Kaur; Reena Gupta; Murtaza M Tambuwala
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 4.473

Review 3.  Colorectal cancer in inflammatory bowel disease: review of the evidence.

Authors:  D S Keller; A Windsor; R Cohen; M Chand
Journal:  Tech Coloproctol       Date:  2019-01-30       Impact factor: 3.781

Review 4.  Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review.

Authors:  Ruben J Colman; David T Rubin
Journal:  Intest Res       Date:  2016-06-27

5.  Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease.

Authors:  Lik Hang Lee; Marietta Iacucci; Miriam Fort Gasia; Subrata Ghosh; Remo Panaccione; Stefan Urbanski
Journal:  Can J Gastroenterol Hepatol       Date:  2017-01-15

6.  Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease.

Authors:  Natasa Smrekar; David Drobne; Lojze M Smid; Ivan Ferkolj; Borut Stabuc; Alojz Ihan; Andreja Natasa Kopitar
Journal:  Radiol Oncol       Date:  2018-11-26       Impact factor: 2.991

7.  Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.

Authors:  Rongjuan Zheng; Jiaheng Ma; Dan Wang; Wenxiao Dong; Sinan Wang; Tianyu Liu; Runxiang Xie; Li Liu; Bangmao Wang; Hailong Cao
Journal:  Mediators Inflamm       Date:  2018-10-25       Impact factor: 4.711

8.  Gastrointestinal neoplasia in patients with inflammatory bowel disease: Opportunities to enhance preventative strategies.

Authors:  Edward Young; Matthew Lawrence; Michelle Thomas; Jane Andrews
Journal:  JGH Open       Date:  2019-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.